SC 13G Filing

Company

ENANTA PHARMACEUTICALS INC

Filed

September 27, 2019

Accession Number

0001214659-19-006069

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →